Tag: action

NEW YORK, June 05, 2025 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP reminds investors who purchased UroGen Pharma Ltd. (“UroGen” or the “Company”) (NASDAQ:URGN) securities to contact Thomas W. Elrod of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below, to discuss your rights or interests with respect to the securities fraud class action lawsuit against the Company.

NEW YORK, June 05, 2025 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP reminds investors of the July 7, 2025, deadline to seek the role of lead plaintiff in a federal securities class action filed on behalf of investors who acquired West Pharmaceutical Services, Inc. (“West” or the “Company”) (NYSE:WST) securities during the period from February 16, 2023, through February 12, 2025 (“the Class Period”).

Stockholders of LRFC Who Have Voted Thus Far Have Expressed Strong Support for the Proposed Merger

Stockholders of PTMN Who Have Voted Thus Far Have Expressed Strong Support for the Proposed Merger

MONTRÉAL, 05 juin 2025 (GLOBE NEWSWIRE) -- Saputo inc. (TSX : SAP) (« nous » , « Saputo » ou « la Société ») a divulgué aujourd’hui ses résultats financiers pour le quatrième trimestre et l'exercice financier clos le 31 mars 2025. Sauf indication contraire, tous les montants figurant dans le présent communiqué de presse sont exprimés en millions de dollars canadiens (CAD), à l'exception des données par action, et sont présentés conformément aux Normes internationales d’information financière (IFRS).

NEW YORK, June 05, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Backblaze, Inc. (NASDAQ: BLZE) resulting from allegations that Backblaze may have issued materially misleading business information to the investing public.

PHILADELPHIA, June 05, 2025 (GLOBE NEWSWIRE) -- Berger Montague PC advises investors that a securities class action lawsuit has been filed against Organon & Co. (“Organon” or the “Company”) (NYSE: OGN) on behalf of purchasers of Organon securities between October 31, 2024 through April 30, 2025, inclusive (the “Class Period”).